Summit Therapeutics financial statements

서밋 테라퓨틱스NASDAQ:SMMT · Nasdaq · Healthcare · sector #17
$17.95+3.70%
2026-10-07 close

Summit Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$226M.

Reported results

Summit Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy